Percutaneous management of paravalvular leaks

Joel P Giblett1,2, Bushra S Rana1, Leonard M Shapiro1

  • 1Department of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.

Insights

Paravalvular leak (PVL) closure is a common complication after valve surgery. Percutaneous closure is now the primary treatment, offering improved outcomes and reduced complications.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Paravalvular leak (PVL) occurs in 5-17% of patients post-prosthetic valve implantation.
  • While often benign, PVLs can lead to significant morbidity and mortality.
  • Percutaneous closure is the current first-line treatment for PVL.

Purpose of the Study:

  • To review the frequency and clinical consequences of PVL closure.
  • To discuss the role of cardiac imaging in PVL assessment and management.
  • To summarize clinical evidence for percutaneous PVL closure.

Main Methods:

  • Review of literature on paravalvular leak (PVL) closure.
  • Discussion of cardiac imaging techniques (echocardiography, CT) for PVL assessment.
  • Analysis of national registries and comparative data for percutaneous vs. surgical closure.

Main Results:

  • Percutaneous closure is effective and becoming the standard of care for PVL.
  • Cardiac imaging plays a crucial role in guiding PVL closure procedures.
  • Evidence from registries supports the efficacy of percutaneous closure compared to surgical options.

Conclusions:

  • Percutaneous closure is the preferred treatment for paravalvular leaks.
  • Comprehensive imaging is essential for successful PVL management.
  • Clinical data support the safety and efficacy of percutaneous PVL closure.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
429
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
216
Managing Impressions01:19

Managing Impressions

Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
171
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
634
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
537
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
286